Literature DB >> 6236548

Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages.

H Rollag, M Degré, G Sonnenfeld.   

Abstract

The influence of murine alpha/beta-interferon (Mu IFN-alpha/beta) and murine gamma-interferon (Mu IFN-gamma) preparations on the attachment and ingestion phase of phagocytosis by mouse peritoneal macrophages (MPM) was studied. A non-opsonized strain of Escherichia coli, IgG-opsonized E. coli, and sheep erythrocytes opsonized with IgG (E-IgG) and IgM plus complement factor C3b (E-IgMC) were used as test particles. Pretreatment of MPM with 10(2)-10(3) U/ml of Mu IFN-alpha/beta for 24 h enhanced both attachment and ingestion of bacteria or erythrocytes mediated by the non-specific receptor, the Fc receptor, or the C3b receptor. Higher concentrations had no such effects. In contrast, treatment of MPM with 10(1)-10(2)U/ml of Mu IFN-gamma suppressed attachment and ingestion of non-opsonized and IgG-opsonized E. coli and of E-IgG by 10-40%. Mu IFN-gamma did not influence attachment and ingestion of E-IgMC. The effects were neutralized by specific anti-IFN antiserum. The data indicate that the IFN effect on phagocytic activity is, at least to a large extent, due to modifications of the surface receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6236548     DOI: 10.1111/j.1365-3083.1984.tb00988.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Immunocytochemical analyses and targeted gene disruption of GTPBP1.

Authors:  S Senju; K Iyama; H Kudo; S Aizawa; Y Nishimura
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis.

Authors:  R A Fratti; M A Ghannoum; J E Edwards; S G Filler
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Host and bacterial factors involved in the innate ability of mouse macrophages to eliminate internalized unopsonized Escherichia coli.

Authors:  T S Hamrick; E A Havell; J R Horton; P E Orndorff
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

4.  A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model.

Authors:  Camille Jacques; Irene Marchesi; Francesco Paolo Fiorentino; Mathias Chatelais; Nicoletta Libera Lilli; Kurt Appel; Beatrice Lejeune; Ilaria Floris
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

5.  Effects of cytokines on intracellular growth of Brucella abortus.

Authors:  X Jiang; C L Baldwin
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

6.  Induction of an atypical interferon by bacteroides fragilis and Escherichia coli in experimental infections and in leukocyte cultures.

Authors:  D K Blanchard; A C Rodloff; W E Steward; H Hahn; H Friedman
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

7.  Recombinant human interferon alpha 2b prevents and reverses experimental pulmonary hypertension.

Authors:  Eileen M Bauer; Han Zheng; Michael T Lotze; Philip M Bauer
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

8.  Abrogation of type-I interferon signalling alters the microglial response to Aβ1-42.

Authors:  Zachery Moore; Frank Mobilio; Frederick R Walker; Juliet M Taylor; Peter J Crack
Journal:  Sci Rep       Date:  2020-02-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.